Real world experience with dimethyl fumarate in relapsing-remitting multiple sclerosis

被引:0
|
作者
Cox, S. R. [1 ]
Jordan, S. [1 ]
Sharma, D. [1 ]
O'Boyle, G. [1 ]
Tubridy, N. [2 ]
Hutchinson, M. [2 ]
Mcguigan, C. [2 ]
机构
[1] Univ Coll Dublin, Neurol, Dublin, Ireland
[2] St Vincents Univ Hosp, Neurol, Dublin, Ireland
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1178
引用
收藏
页码:614 / 615
页数:2
相关论文
共 50 条
  • [21] Characterization of lymphopenia in relapsing-remitting multiple sclerosis patients treated with dimethyl fumarate and fingolimod
    Nakhaei-Nejad, M.
    Barilla, D.
    Lee, C-H.
    Blevins, G.
    Giuliani, F.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 618 - 618
  • [22] Dimethyl Fumarate-Induced Takotsubo Cardiomyopathy in a Patient With Relapsing-Remitting Multiple Sclerosis
    Srichawla, Bahadar S.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [23] Acute pancreatitis: possible association of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis
    Hongxiu Luo
    Harsh Bhatt
    Shaza Mohamad
    Eric Uhrik
    Shuvendu Sen
    Teena Mathew
    Abdalla Yousif
    [J]. Journal of Neurology, 2015, 262 : 779 - 780
  • [24] Diroximel fumarate and dimethyl fumarate demonstrate early clinical and radiological efficacy in relapsing-remitting multiple sclerosis
    Singer, Barry A.
    Shafer, S. James
    Arnold, Douglas L.
    Bowen, James D.
    LaGanke, Christopher
    Chen, Hailu
    Hanna, Jerome
    Miller, Catherine
    Leigh-Pemberton, Richard
    Naismith, Robert T.
    [J]. NEUROLOGY, 2020, 94 (15)
  • [25] Clinical evaluation of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis: efficacy, safety, patient experience and adherence
    Narapureddy, Bhavya
    Dubey, Divyanshu
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2019, 13 : 1655 - 1666
  • [26] Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience
    D'Amico, Emanuele
    Zanghi, Aurora
    Callari, Graziella
    Borriello, Giovanna
    Gallo, Antonio
    Graziano, Giusi
    Valentino, Paola
    Buccafusca, Maria
    Cottone, Salvatore
    Salemi, Giuseppe
    Ragonese, Paolo
    Bossio, Roberto Bruno
    Docimo, Renato
    Grimaldi, Luigi Maria Edoardo
    Pozzilli, Carlo
    Tedeschi, Gioacchino
    Zappia, Mario
    Patti, Francesco
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
  • [27] A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis
    Allan, Michelle
    Grant, Lindsay
    [J]. NEUROLOGY AND THERAPY, 2020, 9 (01) : 85 - 92
  • [28] Alemtuzumab in The Treatment of Relapsing-Remitting Multiple Sclerosis (MS): Real World Experience from Singapore
    Quek, A. M. L.
    Lee, K. E.
    Soon, D.
    Ong, B. K. C.
    Tye, J. S. N.
    Tan, K.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 463 - 464
  • [29] Dimethyl Fumarate: A Review in Relapsing-Remitting MS
    Hannah A. Blair
    [J]. Drugs, 2019, 79 : 1965 - 1976
  • [30] Timecourse of Treatment Effects of BG-12 (Dimethyl Fumarate) for Relapsing-Remitting Multiple Sclerosis
    Kappos, Ludwig
    Giovannoni, Gavin
    Gold, Ralf
    Fox, Robert
    Phillips, J. Theodore
    Hotermans, Christophe
    Zhang, Annie
    Viglietta, Vissia
    Miller, David
    [J]. NEUROLOGY, 2013, 80